基本信息
views: 787
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Ghobrial's research and clinical efforts focus on early detection and interception to prevent progression in Multiple Myeloma. She has a broad background in the biology of multiple myeloma and the bone marrow niche, specifically focusing on MGUS and Smoldering myeloma (SMM) and defining both cell-autonomous and bone marrow niche-dependent mechanisms of disease progression. Her group examines genetic and epigenetic alterations that regulate clonal progression and the role of the bone marrow niche in disease progression from early precursor stages (MGUS and SMM) to active Multiple Myeloma. She is the PI of PROMISE and PCROWD, observational cohort studies that are screening 30,000 individuals and following over 3,000 patients with MGUS and SMM. She has led several clinical trials in high-risk smoldering myeloma including immunotherapeutic precision interventions. All of these pursuits are focused on understanding and preventing the development of myeloma and other hematological malignancies.
Dr. Ghobrial's laboratory research is focused on understanding how early precursor conditions like MGUS and SMM progress to overt MM. We examine the genetic, epigenetic, and immune alterations that clonal progression and the role of the bone marrow niche in disease progression to active Multiple Myeloma. We work to understand the biological changes that occur during progression and develop therapeutic strategies to stop progression in its tracks. In addition, her research has been translated to innovative investigator-initiated clinical trials. She has led over 15 phase I and II clinical trials, and studies on the bone marrow and immune microenvironments are currently being translated into immunotherapy trials in high-risk precursor patients.
Research Interests
Papers共 858 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 6_Supplement (2024): 3447-3447
BLOOD ADVANCESno. 7 (2024): 1737-1746
CLINICAL CANCER RESEARCHno. 4 (2024): 922-922
Clinical Cancer Research (2024)
David M Cordas Dos Santos, Tobias Tix,Roni Shouval, Anat Gafter-Gvili, Jean-Baptiste Alberge,Edward R Scheffer Cliff,Sebastian Theurich, Michael von Bergwelt-Baildon,Irene M Ghobrial, Marion Subklewe,Miguel-Angel Perales,Kai Rejeski
Nature medicine (2024)
Hematology/Oncology Clinics of North Americano. 4 (2024): 743-753
JMIR research protocols (2024): e51368-e51368
Blood cancer discoveryno. 3 (2024): 146-152
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn